Controversy: Should all patients with FLT3-positive AML go to transplant?
Friday, October 25th, 2024
14:15-15:15
Chair: Prof. Lars Bullinger, Charité Berlin
| AGENDA | |
|---|---|
| 14:15-14:20 | Introduction Lars Bullinger |
| 14:20-14:35 | Should all patients with FLT3-positive AML go to transplant? YES Thomas Schroeder |
| 14:35-14:50 | Should all patients with FLT3-positive AML go to transplant? NO Hildegard Greinix |
| 14:50-15:10 | Discussion All |
| 15:10-15:15 | Closure Lars Bullinger |
